Coherus Oncology, Inc. (FRA:8C5)

Coherus Oncology Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 19, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	207	154	336	728	1,078	1,024
Market Cap Growth	55.83%	-54.23%	-53.89%	-32.48%	5.27%	-9.02%
Enterprise Value	90	348	650	909	1,034	953
Last Close Price	1.44	1.41	2.98	6.75	15.00	13.76
PE Ratio	1.57	5.58	-	-	-	9.47
PS Ratio	0.87	0.60	1.44	3.68	3.75	2.63
PB Ratio	2.76	-1.20	-1.92	-5.66	12.54	4.46
P/TBV Ratio	6.34	-	-	-	13.02	4.51
P/FCF Ratio	-	-	-	-	-	8.52
P/OCF Ratio	-	-	-	-	-	8.12
EV/Sales Ratio	0.38	1.35	2.79	4.60	3.60	2.45
EV/EBITDA Ratio	-	-	-	-	-	7.32
EV/EBIT Ratio	-	-	-	-	-	7.46
EV/FCF Ratio	-	-	-	-	-	7.93
Debt / Equity Ratio	0.62	-2.26	-2.49	-3.50	4.29	1.48
Debt / EBITDA Ratio	-	-	-	-	-	2.57
Debt / FCF Ratio	-	-	-	-	-	2.84
Net Debt / Equity Ratio	-1.56	-1.31	-1.88	-2.10	0.02	-0.44
Net Debt / EBITDA Ratio	1.72	-1.94	-1.92	-1.14	-0.01	-0.78
Net Debt / FCF Ratio	1.52	-8.45	-2.08	-1.20	-0.05	-0.84
Asset Turnover	0.54	0.50	0.46	0.36	0.43	0.76
Inventory Turnover	4.88	1.77	3.14	1.83	1.41	1.39
Quick Ratio	1.19	0.88	1.14	2.17	3.27	4.79
Current Ratio	1.24	1.21	1.43	2.75	3.64	5.27
Return on Equity (ROE)	-	-	-	-	-151.62%	68.49%
Return on Assets (ROA)	-10.26%	-10.94%	-21.75%	-27.68%	-21.68%	15.63%
Return on Invested Capital (ROIC)	-	-89.73%	-120.38%	-204.79%	-205.76%	110.66%
Return on Capital Employed (ROCE)	-58.10%	-57.00%	-64.90%	-75.10%	-51.30%	22.50%
Earnings Yield	63.87%	17.93%	-64.15%	-37.52%	-23.43%	10.56%
FCF Yield	-	-12.86%	-47.16%	-31.01%	-3.16%	11.73%
Buyback Yield / Dilution	-2.22%	-21.95%	-21.30%	-2.89%	9.63%	-14.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.